Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fenoterol adverse reaction |
Causative agent (attribute) |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
1 |
Allergy to fenoterol |
Causative agent (attribute) |
False |
Fenoterol (substance) |
Inferred relationship |
Some |
|
Product containing fenoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
1 |
Fenoterol hydrobromide (substance) |
Is a |
False |
Fenoterol (substance) |
Inferred relationship |
Some |
|
Fenoterol hydrobromide+ipratropium bromide 500micrograms/1.25mg nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenoterol (substance) |
Inferred relationship |
Some |
|
Product containing fenoterol and ipratropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |
Allergy to fenoterol |
Causative agent (attribute) |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
1 |
Fenoterol hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
|
Product containing only fenoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
1 |
Fenoterol and ipratropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |
Fenoterol and ipratropium only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing fenoterol and ipratropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fenoterol (substance) |
Inferred relationship |
Some |
2 |